Macrophages in Innate and Acquired Immunity

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 1, 2004, Pages 21-31

  Twigg III, Homer L ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alveolar macrophage; Cytokines; Immune response; Phagocytosis

Indexed keywords

CYTOKINE;

ACCESSORY CELL; ANTIGEN SPECIFICITY; CELL ACTIVATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FOREIGN BODY; HOST RESISTANCE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; MEDIATOR RELEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW;

EID: 1542273549     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822302     Document Type: Review

References (88)

1. Thomas E, Ramberg R, Sale G. Direct evidence for a bone marrow origin of the alveolar macrophages in man. Science 1976;192:1016-1080
2. Bitterman PG, Saltzman LE, Adelberg S, Ferrans VJ, Crystal RG. Alveolar macrophage replication: one mechanism for the expansion of the mononuclear phagocytes population in the chronically inflamed lung. J Clin Invest 1984;74:460-469
3. Spiteri MA, Clarke SW, Poulter LW. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J 1992;5:717-726
4. Kradin RL, Sakamoto H, Preffer FI, Dombkowski D, Springer KM, Leary CP. Accumulation of macrophages with dendritic cell characteristics in the pulmonary response to Listeria. Am J Respir Crit Care Med 2000;161:535-542
5. Bell D, Young JW, Banchereau J. Dendritic cells. Adv Immunol 1999;72:255-324
6. Lee PT, Holt PG, McWilliam AS. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator. Eur J Immunol 2001;31:2347-2356
7. Grigg J, Riedler J, Robertson CF, Boyle W, Uren S. Alveolar macrophage immaturity in infants and young children. Eur Respir J 1999;14:1198-1205
8. Lee PT, Holt PG, McWilliam AS. Role of alveolar macrophages in innate immunity in neonates: evidence for selective lipopolysaccharide binding protein production by rat neonatal alveolar macrophages. Am J Respir Cell Mol Biol 2000;23:652-661
9. Zissel G, Schlaak M, Muller-Quernheim J. Age-related decrease in accessory cell function of human alveolar macrophages. J Investig Med 1999;47:51-56
10. Corsini E, Viviani B, Lucchi L, Marinovich M, Racchi M, Galli CL. Ontogenesis of protein kinase C βII and its anchoring protein RACK1 in the maturation of alveolar macrophage functional responses. Immunol Lett 2001;76:89-93
11. Glasgow JE, Farrell BE, Fisher ES, Lauffenburger DA, Daniele RP. The motile response of alveolar macrophages. Am Rev Respir Dis 1989;139:320-329
12. Van Oss CJ. Phagocytosis: an overview. Methods Enzymol 1986;132:3-15
13. O'Brien AD, Standiford TJ, Christensen PJ, Wilcoxen SE, Paine R. Chemotaxix of alveolar macrophages in response to signals derived from alveolar epithelial cells. J Lab Clin Med 1998;131:417-424
14. Wright JR, Youmas DC. Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophages. Am J Physiol 1993;264(Lung Cell Mol Physiol):L338-L344
15. Gordon S, Perry VH, Rabinowitz S, Chung LP, Rosen H. Plasma membrane receptors of the mononuclear phagocyte system. J Cell Sci 1988;9(suppl):1-26
16. Kobzik L. Lung macrophage uptake of unopsonized environmental particulates: role of scavenger receptors. J Immunol 1995;155:367-376
17. van Crevel R, Ottenhoff THM, van der Meer JWM. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 2002;15:294-309
18. Pasula R, Wright JR, Kachel DL, Martin WJ II. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest 1999;103:483-490
19. Downing JF, Pasula R, Wright JR, Twigg HL, Martin WJ II. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc Natl Acad Sci USA 1995;92:4848-4852
20. Schagat TL, Wofford JA, Wright JR. Surfactant protein A enhances alveolar macrophage phagocytosis of apoptotic neutrophils. J Immunol 2001;166:2727-2733
21. Hu B, Sonstein J, Christensen PJ, Punturieri A, Curtis JL. Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine alveolar macrophages. J Immunol 2000;165:2124-2133
22. Aggeler J, Werb Z. Initial events during phagocytosis by macrophages viewed from outside and inside the cell: membrane-particle interactions and clathrin. J Cell Biol 1982;94:613-623
23. 2+-independent F-actin assembly and disassembly during Fc receptor-mediated phagocytosis in mouse macrophages. J Cell Biol 1991;113:757-767
24. Nathan CF. Secretion of oxygen intermediates; role in effector functions of activated macrophages. Fed Proc 1982;41:2206-2211
25. Liew FY, Cos FEG. Nonspecific defence mechanism: the role of nitric oxide. Immunol Today 1991;12:A17-A21
26. Albina JE. On the expression of nitric oxide synthase by human macrophages. Why no NO. J Leukoc Biol 1995;58:643-649
27. Lekstrom-Himes JA, Gallin JI. Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 2000;343:1703-1714
28. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993;178:2249-2254
29. Orme IM, Cooper AM. Cytokine/chemokine cascades in immunity to tuberculosis. Immunol Today 1999;20:307-312
30. Heldwein KA, Fenton MJ. The role of Toll-like receptors in immunity against mycobacterial infection. Microbes Infect 2002;4:937-944
31. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000;164:2016-2020
32. Mancuso P, Standiford TJ, Marshall T, Peters-Golden M. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect Immun 1998;66:5140-5146
33. Peters-Golden M, Coffey M. Role of leukotrienes in antimicrobial defense of the lung. J Lab Clin Med 1998;132:251-257
34. Coffey MJ, Phare SM, Peters-Golden M. Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol 2000;165:3592-3598
35. Rich EA, Panuska JR, Wallis RS, Wolf CB, Leonard ML, Ellner JJ. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am Rev Respir Dis 1989;139:1010-1016
36. Iwamoto GK, Monick MM, Burmeister LF, Hunninghake GW. Interleukin 1 release by human alveolar macrophages and blood monocytes. Am J Physiol 1989;256(Cell Physiol 25):C1012-C1015
37. Toossi Z, Hirsch CS, Hamilton BP, Knuth CK, Friedlander MA, Rich EA. Decreased production TGF-beta 1 by human alveolar macrophages compared with blood monocytes. J Immunol 1996;156:3461-3468
38. Moore SA, Strieter RM, Rolfe MW, Standiford TJ, Burdick MD, Kunkel SL. Expression and regulation of human alveolar macrophage-derived interleukin-1 receptor antagonist. Am J Respir Cell Mol Biol 1992;6:569-575
39. Martinet Y, Yamauchi K, Crystal RG. Differential expression of tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes. Am Rev Respir Dis 1988;138:659-665
40. Strieter RM, Remick DG, Lynch JP, et al. Differential regulation of tumor necrosis factor-alpha in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am J Respir Cell Mol Biol 1989;1:57-63
41. Standiford TJ, Kunkel SL, Liebler JM, Burdick MD, Gilbert AR, Strieter RM. Gene expression of macrophage inflammatory protein-1α from human blood monocytes and alveolar macrophages is inhibited by interleukin-4. Am J Respir Cell Mol Biol 1993;9:192-198
42. Salez L, Balloy V, van Rooijen N, et al. Surfactant protein A suppresses lipopolysaccharide-induced IL-10 production by murine macrophages. J Immunol 2001;166:6376-6382
43. Soliman DM, Twigg HL. Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages. Am J Physiol 1992;263(Lung Cell Mol Physiol):L471-L478
44. McRea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;150:696-703
45. Standiford TJ, Huffnagle GB. Cytokines in host defense against pneumonia. J Investig Med 1997;6:335-345
46. Martin TR. Overview of cytokine networks in lung injury. In: Pratter MR, Nelson S, eds. Cytokines and Pulmonary Infection Part II: The Role of Cytokines in Systemic and Pulmonary Medicine. ATS Continuing Education Monograph Series. New York, NY: American Lung Association; 1997:19-28
47. Weissler JC, Lipscomb MF, Lem VM, Toews GB. Tumor killing by human alveolar macrophages and blood monocytes. Am Rev Respir Dis 1986;134:532-537
48. Imaizumi K, Kawabe T, Ichiyama S, et al. Enhancement of tumoricidal activity of alveolar macrophages via CD40-CD40 ligand interaction. Am J Physiol 1999;277:L49-L57
49. Sauty A, Manuel J, Philippeaux M, Leuenberger P, Cytostatic activity of alveolar macrophages from smokers and nonsmokers: role of interleukin-1B, interleukin-6, and tumor necrosis factor-α. Am J Respir Cell Mol Biol 1994;11:631-637
50. 1. Exp Lung Res 1994;20:331-349
51. Kaltreider HB, Curtis JL, Arraj SM. The mechanism of appearance of specific antibody-forming cells in the lungs of inbred mice after imunization with sheep erythrocytes intratracheally. Am Rev Respir Dis 1987;135:87-92
52. Curtis JL, Kaltreider HB. Characterization of bronchoalveolar lymphocytes during a specific antibody-forming cell response in the lungs of mice. Am Rev Respir Dis 1989;139:393-400
53. Toews GB, Vial WC, Dunn MM, et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 1984;132:181-186
54. Lipscomb MF, Lyons CR, Nunez G, et al. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J Immunol 1986;136:497-504
55. Lyons CR, Ball EJ, Toews GB, Weissler JC, Stastny P, Lipscomb MF. Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J Immunol 1986;137:1173-1180
56. Holt PG, Oliver J, Bilyk N, et al. Downregulation of the antigen-presenting cell functions(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J Exp Med 1993;177:397-407
57. Ferro TJ, Monos DS, Spear BT. Carbohydrate differences in HLA-DR molecules synthesized by alveolar macrophages and blood monocytes. Am Rev Respir Dis 1987;135:1340-1344
58. Rich EA, Tweardy DJ, Fujiwara H, Ellner JJ. Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis 1987;136:258-265
59. Denham S, Rowland IJ. Inhibition of the reactive proliferation of lymphocytes by activated mcrophages: the role of nitric oxide. Clin Exp Immunol 1992;87:157-162
60. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko T, Erzurum SC, Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 1997;17:279-283
61. Bingisser RM, Tilbrook PA, Holt PG, Kees UR. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway. J Immunol 1998;160:5729-5734
62. Yarbrough WC Jr, Wilkes DS, Weissler JC. Human alveolar macrophages inhibit receptor-mediated increases in intracellular calcium concentration in lymphocytes. Am J Respir Cell Mol Biol 1991;5:411-415
63. Chelen CJ, Yu F, Feeman GJ, et al. Human alveolar macrophages present antigen ineffectively due to defective expression of B7 costimulatory cell surface molecules. J Clin Invest 1995;95:1415-1421
64. Strickland D, Kees UR, Holt PG. Regulation of T-cell activation in the lung: alveolar macrophages induce reversible T-cell anergy in vitro associated with inhibition of interleukin-2 receptor signal transduction. Immunology 1996;87:250-258
65. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J Exp Med 1990;171:1123-1140
66. Balaji KN, Schwander SK, Rich EA, Boom WH. Alveolar macrophages as accessory cells for human γδ T cells activated by Mycobacterium tuberculosis. J Immunol 1995;154:5959-5968
67. Vecchiarelli A, Dottorini M, Pietrella D, et al. Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am J Respir Cell Mol Biol 1994;11:130-137
68. Holt PG. Antigen presentation in the lung. Am J Respir Crit Care Med 2000;162:S151-S156
69. Banchereau J, Bríere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811
70. Zissel G, Ernst M, Schlaak M, Muller-Quernheim: accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med 1997;45:75-86
71. Nicod LP, Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 1997;17:91-96
72. Somoskovi A, Zissel G, Ziegenhagen MW, Schlaak M, Muller-Quernheim J. Accessory function and costimulatory molecule expression of alveolar macrophages in patients with tuberculosis. Immunobiology 2000;201:450-460
73. Twigg HL, Iwamoto GK, Soliman DM. Role of cytokines in alveolar macrophage accessory cell function in HIV-infected individuals. J Immunol 1992;149:1462-1469
74. Agostini C, Facco M, Chilosi M, Semenzato G. Alveolar macrophage-T cell interactions during Th1-type sarcoid inflammation. Microsc Res Tech 2001;53:278-287
75. Bilyk N, Holt PG. Inhibition of the immunosuppressive activity of resident pulmonary alveolar macrophages by granulocyte/macrophage colony-stimulating factor. J Exp Med 1993;177:1773-1777
76. Weissler JC, Mendelson C, Moya F, Yarbrough WC Jr. Effect of insterstitial lung disease macrophages on T-cell signal transduction. Am J Respir Crit Care Med 1994;149:191-196
77. Tang C, Inman MD, van Rooijen N, et al. Th type 1-stimulating activity of lung macrophages inhibits Th2-mediated allergic airway inflammation by an IFN-γ-dependent mechanism. J Immunol 2001;166:1471-1481
78. Tang C, Ward C, Reid D, Bish R, O'Byrne PM, Walters EH. Normally suppressing CD40 coregulatory signals delivered by airway macrophages to Th2 lymphocytes are defective in patients with atopic asthma. J Allergy Clin Immunol 2001;107:863-870
79. Wilkes DS, Yarbrough WC, Weissler JC. Human alveolar macrophages inhibit immunoglobulin production in response to direct B cell mitogen. Am J Respir Cell Mol Biol 1993;9:141-147
80. Bauer W, Gorny NK, Baumann HR, Morell A. T-lymphocyte subsets and immunoglobulin concentrations in bronchoalveolar lavage of patients with sarcoidosis and high and low intensity alveolitis. Am Rev Respir Dis 1985;132:1060-1065
81. Wilkes DS, Weissler JC. Alloantigen-induced immunoglobulin production in human lung: differential effects of accessory cell populations on IgG synthesis. Am J Respir Cell Mol Biol 1994;10:339-346
82. MacLean JA, Xia W, Pinto CE, Zhao L, Liu H-W, Kradin RL. Sequestration of inhaled particulate antigens by lung phagocytes: a mechanism for the effective inhibition of pulmonary cell-mediated immunity. Am J Pathol 1996;148:657-666
83. Wijburg OLC, DiNatale S, Vadolas J, van Rooijen N, Strugnell RA. Alveolar macrophage regulate the induction of primary cytoxic T-lymphocyte responses during influenza virus infection. J Virol 1997;71:9450-9457
84. Debrick JE, Campbell PA, Staerz UD. Macrophages as accessory cells for class I MHC-restricted immune responses. J Immunol 1991;147:2846-2851
85. Quentmeier H, Klaucke J, Muhlradt PF, Drexler HG. Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells. J Immunol 1992;149:3316-3320
86. Plata F, Autran B, Martins LP, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987;328:348-351
87. Lee WC, McConnell I, Blacklaws BA. Cytotoxic activity against Maedi-visna virus-infected macrophages. J Virol 1994;68:8331-8338
88. Bingisser R, Stey C, Weller M, Groscurth P, Russi E, Frei K. Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 1996;15:64-70